{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:21:47Z","timestamp":1782688907047,"version":"3.54.5"},"reference-count":39,"publisher":"JLE","issue":"3","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1684\/ejd.2019.3554","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:34:34Z","timestamp":1696865674000},"page":"287-293","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Livedoid vasculopathy: does hyperhomocysteinaemia play an aetiological role?"],"prefix":"10.1684","volume":"29","author":[{"given":"Wolfgang C.","family":"Marsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Komatsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Hagemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Maemecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Villavicencio-Lorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","published-online":{"date-parts":[[2019,9,25]]},"reference":[{"key":"3554_CR1","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1590\/S0365-05962011000500015","volume":"86","author":"PR Criado","year":"2011","unstructured":"Criado PR, Rivitti EA, Sotto MN, et al. Livedoid vasculopathy: an intriguing cutaneous disease. An Bras Dermatol 2011; 86: 961\u201377.","journal-title":"An Bras Dermatol"},{"key":"3554_CR2","first-page":"407","volume":"11","author":"N Kerk","year":"2013","unstructured":"Kerk N, Goerge T. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction. J Dtsch Dermatol Ges 2013; 11: 407\u201310.","journal-title":"J Dtsch Dermatol Ges"},{"key":"3554_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaad.2013.07.019","volume":"69","author":"A Alavi","year":"2013","unstructured":"Alavi A, Hafner J, Dutz JP, et al. Livedoid vasculopathy: an indepth analysis using a modified Delphi approach. J Am Acad Dermatol 2013; 69: 1033\u201342.","journal-title":"J Am Acad Dermatol"},{"key":"3554_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/archderm.1955.03730310033007","volume":"72","author":"M Feldaker","year":"1955","unstructured":"Feldaker M, Hines EA Jr., Kierland RR. Livedo reticularis with summer ulcerations. Arch Dermatol 1955; 72: 31\u201342.","journal-title":"Arch Dermatol"},{"key":"3554_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jdermsci.2016.01.004","volume":"82","author":"L Yang","year":"2016","unstructured":"Yang L, Murota H, Shindo S, et al. Increased serum CXCR2 ligand levels in livedo vasculopathy with winter ulcerations: possible contribution of neutrophil recruitment to lesional skin. J Dermatol Sci 2016; 82: 57\u20139.","journal-title":"J Dermatol Sci"},{"key":"3554_CR6","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/archderm.1967.01610050011002","volume":"96","author":"JW Bard","year":"1967","unstructured":"Bard JW, Winkelmann RK. Livedo vasculitis. Segmental hyalinizing vasculitis of the dermis. Arch Dermatol 1967; 96: 489\u201399.","journal-title":"Arch Dermatol"},{"key":"3554_CR7","unstructured":"Patterson JW. The vasculopathic reaction pattern. Weedon\u2019s Skin Pathology, 4th ed. Elsevier, 2016: 219-80."},{"key":"3554_CR8","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archdermatol.2010.224","volume":"146","author":"J Hafner","year":"2010","unstructured":"Hafner J, Nobbe S, Partsch H, et al. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol 2010; 146: 961\u20138.","journal-title":"Arch Dermatol"},{"key":"3554_CR9","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archderm.142.11.1413","volume":"142","author":"BR Hairston","year":"2006","unstructured":"Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006; 142: 1413\u20138.","journal-title":"Arch Dermatol"},{"key":"3554_CR10","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.autrev.2010.11.008","volume":"10","author":"PR Criado","year":"2011","unstructured":"Criado PR, Rivitti EA, Sotto MN, de Carvalho JF. Livedoid vasculopathy as a coagulation disorder. Autoimmun Rev 2011; 10: 353\u201360.","journal-title":"Autoimmun Rev"},{"key":"3554_CR11","first-page":"822","volume":"126","author":"AF Didier","year":"1999","unstructured":"Didier AF, Tourand JP, Collet E, Dalac S, Becker F, Lambert D. N\u00e9crose cutan\u00e9e distale, une \u00e9tiologie inhabituelle: l\u2019hyperhomocyst\u00e9in\u00e9mie. Ann Dermatol V\u00e9n\u00e9r\u00e9ol 1999; 126: 822\u20135.","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ol"},{"key":"3554_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0190-9622(99)70207-0","volume":"40","author":"GE Gibson","year":"1999","unstructured":"Gibson GE, Li H, Pittelkow MR. Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol 1999; 40: 279\u201381.","journal-title":"J Am Acad Dermatol"},{"key":"3554_CR13","first-page":"159","volume":"16","author":"F Meiss","year":"2006","unstructured":"Meiss F, Marsch WC, Fischer M. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 2006; 16: 159\u201362.","journal-title":"Eur J Dermatol"},{"key":"3554_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jaad.2013.01.043","volume":"69","author":"LA Thornsberry","year":"2013","unstructured":"Thornsberry LA, LoSicco KI, English JC. 3rd KI. The skin and hypercoagulable states. J Am Acad Dermatol 2013; 69: 450\u201362.","journal-title":"J Am Acad Dermatol"},{"key":"3554_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/nan.12243","volume":"41","author":"Y Allenbach","year":"2015","unstructured":"Allenbach Y, Tourte M, Stenzel W, et al. Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations. Neuropathol Appl Neurobiol 2015; 41: 849\u201352.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3554_CR16","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jns.2015.03.013","volume":"351","author":"MC Malaguti","year":"2015","unstructured":"Malaguti MC, Cavallaro T, Spezial T, Zorzi MG, Marangoni S, Morini A. Mononeuritis multiplex associated with primary livedoid vasculopathy: neuropathological evidence of ischemic nerve damage. J Neurol Sci 2015; 351: 214\u20135.","journal-title":"J Neurol Sci"},{"key":"3554_CR17","first-page":"120","volume":"9","author":"E Previtali","year":"2011","unstructured":"Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus 2011; 9: 120\u201338.","journal-title":"Blood Transfus"},{"key":"3554_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111\u20133.","journal-title":"Nat Genet"},{"key":"3554_CR19","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1086\/301825","volume":"62","author":"NM van der Put","year":"1998","unstructured":"van der Put NM, Gabreels F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62: 1044\u201351.","journal-title":"Am J Hum Genet"},{"key":"3554_CR20","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-0038-1642781","volume":"59","author":"C Kluft","year":"1988","unstructured":"Kluft C, Jie AF, Rijken DC, Verheijen JH. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1). Thromb Haemost 1988; 59: 329\u201332.","journal-title":"Thromb Haemost"},{"key":"3554_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.02.002","volume":"16","author":"S Saidi","year":"2007","unstructured":"Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY. Association of PAI-1 4G\/5G and -844G\/A gene polymorphism and changes in PAI-1\/tPA levels in stroke: a case-control study. J Stroke Cerebrovasc Dis 2007; 16: 153\u20139.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3554_CR22","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther 2010; 28: e72\u201391.","journal-title":"Cardiovasc Ther"},{"key":"3554_CR23","first-page":"1466","volume":"142","author":"A Deng","year":"2006","unstructured":"Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G\/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 2006; 142: 1466\u20139.","journal-title":"Arch Dermatol"},{"key":"3554_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2340\/00015555-0760","volume":"90","author":"J Antunes","year":"2010","unstructured":"Antunes J, Filipe P, Andre M, Fraga A, Miltenyi G, Marques Gomes M. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G\/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy. Acta Derm Venereol 2010; 90: 91\u20132.","journal-title":"Acta Derm Venereol"},{"key":"3554_CR25","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMra1700365","volume":"377","author":"JM Connors","year":"2017","unstructured":"Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017; 377: 2297\u20138.","journal-title":"N Engl J Med"},{"key":"3554_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1538-7836.2007.02311.x","volume":"5","author":"FW Asselbergs","year":"2007","unstructured":"Asselbergs FW, Williams SM, Hebert PR, et al. Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits. J Thromb Haemost 2007; 5: 313\u201320.","journal-title":"J Thromb Haemost"},{"key":"3554_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","volume":"29","author":"JC Chapin","year":"2015","unstructured":"Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev 2015; 29: 17\u201324.","journal-title":"Blood Rev"},{"key":"3554_CR28","first-page":"212","volume":"55","author":"RH Turner","year":"1969","unstructured":"Turner RH, Ryan TJ. Fibrinolytic activity in human skin. Trans St Johns Hosp Dermatol Soc 1969; 55: 212\u20137.","journal-title":"Trans St Johns Hosp Dermatol Soc"},{"key":"3554_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/jid.1969.176","volume":"53","author":"RH Turner","year":"1969","unstructured":"Turner RH, Kurban AK, Ryan TJ. Fibrinolytic activity in human skin following epidermal injury. J Invest Dermatol 1969; 53: 458\u201362.","journal-title":"J Invest Dermatol"},{"key":"3554_CR30","doi-asserted-by":"publisher","first-page":"e12255","DOI":"10.1111\/1755-5922.12255","volume":"35","author":"M Agirbasli","year":"2017","unstructured":"Agirbasli M, Goktay F, Peker I, Gunes P, Aker FV, Akkiprik M. Enhanced mRNA expression of plasminogen activator inhibitor-1 in livedoid vasculopathy lesions. Cardiovasc Ther 2017; 35: e12255.","journal-title":"Cardiovasc Ther"},{"key":"3554_CR31","first-page":"3384","volume":"119","author":"AT Jacovina","year":"2009","unstructured":"Jacovina AT, Deora AB, Ling Q, et al. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. J Clin Invest 2009; 119: 3384\u201394.","journal-title":"J Clin Invest"},{"key":"3554_CR32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/archdermatol.2010.177","volume":"146","author":"T Goerge","year":"2010","unstructured":"Goerge T, Weishaupt C, Metze D, et al. Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparin. Arch Dermatol 2010; 146: 927\u20138.","journal-title":"Arch Dermatol"},{"key":"3554_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1365-2133.2011.10216.x","volume":"164","author":"R Vasconcelos","year":"2011","unstructured":"Vasconcelos R, Criado PR, Belda W Jr.. Livedoid vasculopathy secondary to high levels of lipoprotein (a). Br J Dermatol 2011; 164: 1111\u20133.","journal-title":"Br J Dermatol"},{"key":"3554_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/cup.13043","volume":"44","author":"DPGS Espinel","year":"2017","unstructured":"Espinel DPGS, Di Giacomo TB, Pincelli TP, et al. Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy. J Cutan Pathol 2017; 44: 1033\u20137.","journal-title":"J Cutan Pathol"},{"key":"3554_CR35","first-page":"44","volume":"1","author":"F van Buuren","year":"2017","unstructured":"van Buuren F, Horstkotte D, Knabbe C, Hinse D, Mellwig KP. Incidence of elevated lipoprotein(a) levels in a large cohort of patients with cardiovascular disease. Clin Res Cardiol Suppl 2017; 1: 44\u20139.","journal-title":"Clin Res Cardiol Suppl"},{"key":"3554_CR36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.atherosclerosis.2014.01.054","volume":"234","author":"F Kronenberg","year":"2014","unstructured":"Kronenberg F. Lipoprotein(a) in various conditions: to keep a sense of proportions. Atherosclerosis 2014; 234: 249\u201351.","journal-title":"Atherosclerosis"},{"key":"3554_CR37","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/ndt\/gfl044","volume":"21","author":"C van Guldener","year":"2006","unstructured":"van Guldener C. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant 2006; 21: 1161\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"3554_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jamadermatol.2017.4374","volume":"154","author":"R Micieli","year":"2018","unstructured":"Micieli R, Alavi A. Treatment for livedoid vasculopathy: a systematic review. JAMA Dermatol 2018; 154: 193\u2013202.","journal-title":"JAMA Dermatol"},{"key":"3554_CR39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2340\/00015555-2416","volume":"96","author":"E Errichetti","year":"2016","unstructured":"Errichetti E, Stinco G. Recalcitrant livedoid vasculopathy associated with hyperhomocysteinaemia responding to folic acid and vitamins B6\/B12 supplementation. Acta Derm Venereol 2016; 96: 987\u20138.","journal-title":"Acta Derm Venereol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2019.3554\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:20:46Z","timestamp":1741191646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3554"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2019.3554","relation":{},"ISSN":["1952-4013"],"issn-type":[{"value":"1952-4013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"23 November 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Disclosure. Financial support: none. Conflicts of interest: none.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}